These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening. Monostori P, Szabó P, Marginean O, Bereczki C, Karg E. Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944 [Abstract] [Full Text] [Related]
11. Recent progress in neonatal mass screening for congenital hypothyroidism and adrenal hyperplasia using enzyme immunoassays. Tsuji A, Maeda M, Arakawa H. Adv Clin Chem; 1990 Nov 01; 28():109-43. PubMed ID: 2077875 [No Abstract] [Full Text] [Related]
12. Congenital adrenal hyperplasia and violation of newborn screening procedures. Odajima H, Hosono S, Kayama K, Yoshikawa K, Takahashi S. Pediatr Int; 2017 Oct 01; 59(10):1107-1108. PubMed ID: 28960615 [No Abstract] [Full Text] [Related]
13. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study. Gidlöf S, Wedell A, Guthenberg C, von Döbeln U, Nordenström A. JAMA Pediatr; 2014 Jun 01; 168(6):567-74. PubMed ID: 24733564 [Abstract] [Full Text] [Related]
16. Neonatal screening for congenital adrenal hyperplasia in Japan. Tajima T, Fujikura K, Fukushi M, Hotsubo T, Mitsuhashi Y. Pediatr Endocrinol Rev; 2012 Oct 01; 10 Suppl 1():72-8. PubMed ID: 23330248 [Abstract] [Full Text] [Related]
17. The value of time in assessing the effectiveness of newborn screening for congenital adrenal hyperplasia. Tarini BA. JAMA Pediatr; 2014 Jun 01; 168(6):515-6. PubMed ID: 24733500 [No Abstract] [Full Text] [Related]
18. Does newborn screening have 100% sensitivity to detect salt wasting congenital adrenal hyperplasia?-Reply. Gidlöf S, Nordenström A. JAMA Pediatr; 2014 Oct 01; 168(10):971. PubMed ID: 25285872 [No Abstract] [Full Text] [Related]